| Dr Jenna Marie Peart, MD | |
|
2750 Broadway St, Boulder, CO 80304-3586 | |
| (303) 440-3013 | |
| (303) 440-3178 |
| Full Name | Dr Jenna Marie Peart |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 9 Years |
| Location | 2750 Broadway St, Boulder, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912391285 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | TL.0005705 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boulder Medical Center, Pc | 4183536204 | 79 |
News Archive
Cutaneous angiosarcoma is a rare, highly aggressive skin tumor found primarily on the scalps of older White people, but based on new research from the University of North Carolina School of Medicine and the Lineberger Comprehensive Cancer Center, immunotherapies effective against lung cancer and melanoma may also work against this cancer.
Aeterna Zentaris Inc. earlier today, presented positive final Phase 2 efficacy and safety data for its targeted cytotoxic luteinizing hormone releasing hormone (LHRH) analog, AEZS-108, in advanced endometrial cancer.
A new study at the MedUni Vienna's Comprehensive Cancer Center is assessing patients with metastasised bowel cancer to determine whether it is possible to characterise tumour and better control resistance mechanisms with a blood test. The aim of this is to spare patients the stress of having tissue removed via biopsies and to make the targeted use of therapy easier.
The January issue of the American Headache Society journal Headache provides an updated assessment of the best treatments to use when a migraine attack occurs. The assessment will form the basis of new AHS treatment guidelines.
› Verified 2 days ago
| Entity Name | Boulder Medical Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306820923 PECOS PAC ID: 4183536204 Enrollment ID: O20031105000512 |
News Archive
Cutaneous angiosarcoma is a rare, highly aggressive skin tumor found primarily on the scalps of older White people, but based on new research from the University of North Carolina School of Medicine and the Lineberger Comprehensive Cancer Center, immunotherapies effective against lung cancer and melanoma may also work against this cancer.
Aeterna Zentaris Inc. earlier today, presented positive final Phase 2 efficacy and safety data for its targeted cytotoxic luteinizing hormone releasing hormone (LHRH) analog, AEZS-108, in advanced endometrial cancer.
A new study at the MedUni Vienna's Comprehensive Cancer Center is assessing patients with metastasised bowel cancer to determine whether it is possible to characterise tumour and better control resistance mechanisms with a blood test. The aim of this is to spare patients the stress of having tissue removed via biopsies and to make the targeted use of therapy easier.
The January issue of the American Headache Society journal Headache provides an updated assessment of the best treatments to use when a migraine attack occurs. The assessment will form the basis of new AHS treatment guidelines.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jenna Marie Peart, MD 2750 Broadway St, Boulder, CO 80304-3586 Ph: (303) 440-3013 | Dr Jenna Marie Peart, MD 2750 Broadway St, Boulder, CO 80304-3586 Ph: (303) 440-3013 |
News Archive
Cutaneous angiosarcoma is a rare, highly aggressive skin tumor found primarily on the scalps of older White people, but based on new research from the University of North Carolina School of Medicine and the Lineberger Comprehensive Cancer Center, immunotherapies effective against lung cancer and melanoma may also work against this cancer.
Aeterna Zentaris Inc. earlier today, presented positive final Phase 2 efficacy and safety data for its targeted cytotoxic luteinizing hormone releasing hormone (LHRH) analog, AEZS-108, in advanced endometrial cancer.
A new study at the MedUni Vienna's Comprehensive Cancer Center is assessing patients with metastasised bowel cancer to determine whether it is possible to characterise tumour and better control resistance mechanisms with a blood test. The aim of this is to spare patients the stress of having tissue removed via biopsies and to make the targeted use of therapy easier.
The January issue of the American Headache Society journal Headache provides an updated assessment of the best treatments to use when a migraine attack occurs. The assessment will form the basis of new AHS treatment guidelines.
› Verified 2 days ago
Max Russell Greenlee Jr., M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 870 Juniper Ave, Boulder, CO 80304 Phone: 303-442-3425 Fax: 303-442-3425 | |
Shawn B Allen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2880 Folsom St Ste 200, Boulder, CO 80304 Phone: 303-442-6647 Fax: 303-442-2696 | |
Mr. William Crane Fix, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1840 Folsom St Ste 100, Boulder, CO 80302 Phone: 720-741-8051 | |
Dr. Steven D Resnick, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3575 Broadway St, Boulder, CO 80304 Phone: 303-449-0933 Fax: 303-447-0794 | |
John R Steinbaugh, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3575 Broadway St, Boulder, CO 80304 Phone: 303-449-0933 Fax: 303-447-0794 | |
Dr. Brian N Bailey, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1230 Chambers Dr, Boulder, CO 80305 Phone: 303-666-8288 | |
Lindsay Nicole Boyers, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2750 Broadway St, Boulder, CO 80304 Phone: 303-440-3013 Fax: 303-440-3178 |